SCHEMBL1454329

SCHEMBL1454329

Fc1ccc([Zn]Cl)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL4049605 0.97 CA1 (0.36) —
SCHEMBL13859438 0.76 CA1 (0.44) —
SCHEMBL13499 0.71 — —
SCHEMBL8015144 0.69 CES2 (0.36) —
SCHEMBL4008449 0.69 — —
SCHEMBL954349 0.69 — —
SCHEMBL6560890 0.67 — —
Fluoride SCHEMBL21816906 0.67 CA1 (0.57) —
Bromide SCHEMBL6770232 0.67 — —
Iodide SCHEMBL2216576 0.66 ACHE (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012155932-A1 IMPROVED PROCESS FOR THE PREPARATION OF EZETIMIBE PHARMATHEN S.A. (GR) 2012-11-22 — — WO claimed
EP-1819684-B1 SUBSTITUTED PIPERAZINES AS CB1 ANTAGONISTS INTERVET INT BV (NL) 2013-08-07 — — EP disclosed
US-20130190487-A1 PROCESS FOR THE PREPARATION OF EZETIMIBE AND DERIVATIVES THEREOF KRKA (SL) 2013-07-25 — — US disclosed
US-20130072468-A1 SUBSTITUTED PIPERAZINES AS CB1 ANTAGONISTS GILBERT ERIC J (US) 2013-03-21 — — US disclosed
US-8236805-B2 Substituted piperazines as CB1 antagonists INTERVET INC. (US) 2012-08-07 — — US disclosed
US-RE42461-E1 Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents SCHERING CORPORATION (US) 2011-06-14 — — US disclosed
US-7910783-B2 Preparation of substituted bridged indenyl and related ligands EXXONMOBIL CHEMICAL PATENTS INC. (US) 2011-03-22 — — US disclosed
US-7737154-B2 CRF receptor antagonists and methods relating thereto SMITHKLINE BEECHAM (CORK) LIMITED (IE) 2010-06-15 — — US disclosed
EP-2189442-A1 Process and intermediates for the preparation of aliskiren Krka Tovarna Zdravil, D.D., Novo Mesto (SI) 2010-05-26 — — EP disclosed
US-7700597-B2 Substituted piperazines as CB1 antagonists SCHERING CORPORATION (US) 2010-04-20 — — US disclosed
US-RE37721-E1 Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents SCHERING CORPORATION 2002-05-28 — — US disclosed
EP-0692485-B1 Cyclohexane carbaldehyde compounds and processes for preparing silacyclohexane-based liquid crystal compounds from the carbaldehyde compound SHINETSU CHEMICAL CO (JP) 2000-01-05 — — EP disclosed
EP-0720599-B1 HYDROXY-SUBSTITUTED AZETIDINONE COMPOUNDS USEFUL AS HYPOCHOLESTEROLEMIC AGENTS SCHERING CORP (US) 1999-05-19 — — EP disclosed
US-5846966-A Ezetimibe in combination with statins SCHERING CORPORATION (US) 1998-12-08 — — US disclosed
US-5767115-A ADMINISTERING TO PREVENT ATHERSCLEROSIS OR REDUCING PLASMA CHOLESTEROL LEVELS TO THE MAMMALS; INCLUDES EZETIMIBE SCHERING-PLOUGH CORPORATION (US) 1998-06-16 — — US disclosed
US-5631365-A TREATING LACTONE WITH BASE; REACTING WITH AROMATIC IMINE; LACTAMIZATION SCHERING CORPORATION (US) 1997-05-20 — — US disclosed
EP-0720599-A1 HYDROXY-SUBSTITUTED AZETIDINONE COMPOUNDS USEFUL AS HYPOCHOLESTEROLEMIC AGENTS SCHERING CORPORATION (US) 1996-07-10 — — EP disclosed
US-5519156-A Cyclohexane carbaldehyde compounds and processes for preparing silacyclohexane-based liquid crystal compounds from the carbaldehyde SHIN-ETSU CHEMICAL CO., LTD. (JP) 1996-05-21 — — US disclosed
EP-0692485-A1 Cyclohexane carbaldehyde compounds and processes for preparing silacyclohexane-based liquid crystal compounds from the carbaldehyde compound Shin-Etsu Chemical Co., Ltd. (JP) 1996-01-17 — — EP disclosed
WO-1995008532-A1 HYDROXY-SUBSTITUTED AZETIDINONE COMPOUNDS USEFUL AS HYPOCHOLESTEROLEMIC AGENTS SCHERING CORPORATION (US) 1995-03-30 — — WO disclosed
Send feedback